Hepatocyte FAM210A deficiency disrupts mitochondrial function and triggers juvenile steatosis with compensatory repair in adulthood
Yubo WangiD, Leah Chu, Yumei ZhouiD, Zihao JiniD, Kyoungrae KimiD, Katie D. Heiden, Miguel Angel Gutierrez Monreal, Junxiao ReniD, Yufen LiiD, Zhiyong ChengiD, Kari B. Green BassoiD, Karyn Ann EsseriD, TERENCE EDWARD RYANiD, Feng YueiD
Abstract
Mitochondrial dynamics are central to maintaining liver metabolic homeostasis, yet the mechanisms that safeguarding mitochondrial integrity during development and metabolic dysfunction remain poorly defined. Here, we identify Family with sequence similarity 210 member A (FAM210A) as a hepatocyte-enriched mitochondrial regulator essential for postnatal liver maturation. Hepatocyte-specific deletion of Fam210a (Fam210aHKO) in mice caused early growth restriction, reduced body and liver mass, and pronounced hepatic steatosis with glycogen depletion. These defects were accompanied by lower postprandial glucose levels in the fasted-refeeding state, impaired oxidative phosphorylation, reduced mtDNA content, and abnormal cristae architecture. Transcriptomic and proteomic profiling revealed broad suppression of fatty acid, sterol, and bile acid metabolism, with concomitant glutathione stress responses. Mechanistically, FAM210A deficiency disrupted the YME1L-OPA1 axis, driving excessive OPA1 cleavage and cristae destabilization. Strikingly, these juvenile defects were transient and resolved by adulthood, underpinned by enhanced hepatocyte proliferation and mitochondrial biogenesis, consistent with a compensatory stress-adaptive response via the activation of ISR signaling. Together, these findings uncover FAM210A as a developmental safeguard of mitochondrial remodeling in hepatocytes and indicate compensatory programs with therapeutic relevance for chronic liver disease.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 0th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mtfp1 ablation enhances mitochondrial respiration and protects against hepatic steatosis
C. Patitucci, J. D. Hernandez Camacho, … T. Wai·bioRxiv·Apr 26, 2023
- OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD
Xinting Yu, Pinzhu Huang, … Yury V. Popov·bioRxiv·Sep 27, 2026
- Mitochondrial topoisomerase I (Top1MT) prevents the onset of metabolic dysfunction-associated steatohepatitis (MASH) in mice
S. Baechler, LK Saha, … Yves G. Pommier·bioRxiv·Sep 5, 2024
- A novel role for Oxaloacetate Decarboxylase FAHD1 in cardiomyocyte maturation
Elia Cappuccio, Athanasios Seretis, … Pidder Jansen‐Dürr·bioRxiv·Aug 19, 2026
- Nonalcoholic fatty liver disease is associated with decreased hepatocyte mitochondrial respiration but not mitochondrial number
M. C. Sinton, J. Meseguer-Ripolles, … A. J. Drake·bioRxiv·Mar 10, 2020
- Cardiolipin deficiency disrupts electron transport chain and drives steatohepatitis
Marisa J. Brothwell, Guoshen Cao, … Katsuhiko Funai·eLifePeer-reviewed·Sep 2, 2026